Adicet Bio to Participate in Upcoming Investor Conferences
Business Wire•22/10/2026•16:00 ET
0
Key Highlights
- ➤Adicet Bio (ACET) management to participate in two November investor conferences
- ➤CEO Chen Schor scheduled for Guggenheim fireside chat November 10, 2026
- ➤Adicet management available for one-on-one meetings at Jefferies November 19, 2026
Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta CAR-T cell and in vivo CAR-T therapies for autoimmune diseases, hematologic malignancies and solid tumors, today announced that company management will participate in two upcoming investor conferences in November.
Guggenheim 3(rd) Annual Healthcare Innovation Conference, November 9-11, 2026, Boston, MA
Get started
Create a free account to read the full story.